Company Filing History:
Years Active: 2021-2022
Title: Laura Deveau: Innovator in Coronavirus Research
Introduction
Laura Deveau is a prominent inventor based in Lebanon, NH (US), known for her significant contributions to the field of coronavirus research. With a total of 3 patents, her work focuses on developing antibodies that target the S protein of coronaviruses, including SARS-CoV and SARS-CoV-2.
Latest Patents
Her latest patents include groundbreaking disclosures related to antibodies and antigen binding fragments that exhibit binding specificity for the S protein of coronaviruses. These patents detail the development of neutralizing antibodies and conjugates of anti-CoV-S antibodies, which can be utilized for the diagnosis, assessment, and treatment of diseases associated with coronaviruses. The methods outlined in her patents also encompass the creation of these antibodies and their potential therapeutic applications.
Career Highlights
Laura Deveau is currently associated with Adagio Therapeutics, Inc., where she continues to advance her research in the field of immunology. Her innovative work has positioned her as a key figure in the development of therapeutic solutions for coronavirus-related diseases.
Collaborations
Throughout her career, Laura has collaborated with notable colleagues, including Laura M Walker and Jonathan Belk, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Laura Deveau's contributions to coronavirus research through her patents and collaborations highlight her role as a leading inventor in the field. Her work not only advances scientific understanding but also holds the potential for significant therapeutic benefits.